Pune, India -- (SBWIRE) -- 03/01/2019 -- The market is expected to register a growth rate of 5.8% over forecast period. The worldwide Over-the-Counter (OTC) Drugs Market was valued over US$ 120 Bn in the year 2018. The introduction on new products into market and expanding geriatric population base is expected to accelerate the adoption of Over-the-Counter (OTC) Drugs and hence drive the market growth.

The preference for (OTC) Drugsfrom pharmaceutical industry is increasing significantly and this is observed due to demand from consumers for carrying out self-medication. The shift of pharmaceutical industries to Over-the-Counter (OTC) Drugs is expected to be one of themajor industry trends.

Free Download Sample Report Pages For Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1171

The developing countries are expected to be quick adopter of Over-the-Counter (OTC) drugs as the consumers in this region are more focused on cost reduction by saving the consultation cost required to pay.

The inclination towards the traditional medication methods in few of the underdeveloped economies is expected to be one of the restraining factor for the growth of market.Also, other factors such as substance abuse and incorrect diagnosis are some of the major factors limiting the growth of Over-the-Counter (OTC) drugs market. Also, due to some chemical composition failures or allergic reactions of Over-the-Counter (OTC) drugs have made call back of drugs from stores several times in past years this significantly affects the market in a negative way.

The global Over-the-Counter (OTC) Drugs market is segmented into product, and region. On the basis product, the global Over-the-Counter (OTC) Drugs market is segmented into Analgesics, Cold, Cough & Flu Products, Weight Loss Products, Gastrointestinal Products, Skin Products, Mineral and Vitamin Supplements, Sleeping Aids, Ophthalmic Products. On the basis of region the global agricultural fumigants market is bifurcated into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific.

In terms of demand the Over-the-Counter (OTC) Drugs in the type of minerals, vitamins and supplement are dominating the global market in 2018. This segment is holding major market share of over 25%. The demand for minerals, vitamins and supplement is very high in the developed economies including U.S., Japan, and others. In addition to this, increasing healthcare issues to due changing eating habits is fuelling the demand for minerals, vitamins and supplement as the Over-the-Counter (OTC) Drugs in developing regions as well. Such factors are increasing demand for Over-the-Counter (OTC) Drugs and hence boosting the market growth.

The rise in allergic reactions, frequent aching, and other diet deficiency problems due to changing eating habits and busy lifestyles is boosting the adoption of Over-the-Counter (OTC) drugs at global level. The developed region are becoming increasingly focused on controlling the usage of Over-the-Counter (OTC) drugs to promote the physicians consultations and promote the importance of clinical visits which is limiting the growth of Over-the-Counter (OTC) drugs market in this region. Considering such factors, the North America region is expected to register moderate growth rate. On the other hand,the developing region such as APAC region is expected to witness significant increase in terms of demand for Over-the-Counter (OTC) drugs and China market is holding a significant market share with over 15% of global over-the-counter drugs market share. The strong presence of Over-the-Counter (OTC) drugs manufacturers and increasing production of pharmaceuticals in this region is boosting the demand for drugs.

View Detail Information With Complete TOC@ https://www.acumenresearchandconsulting.com/over-the-counter-otc-drugs-market

Currently, the Over-the-Counter (OTC) drugs market is significantly dominated by some of the potential economies including U.S., Japan, and China. The major economies are foreseen to capture significant market share in the Over-the-Counter (OTC) drugs market in 2018. Considering the demand from consumers for Over-the-Counter (OTC) drugs, the U.S and Japan are expected to register moderate growth rate over forecast period due to saturation in terms of demand and strong regulatory parameters present in these countries.

The Over-the-Counter (OTC) drugsmanufacturers are increasing focusing delivering products as per regulations and standards enforced by governments and different organizations and associations. Some of the key players present in the Over-the-Counter (OTC) drugs market are companies including Dr. Reddy's Laboratories, Sanofi, Merck KGaA, Sun Pharmaceutical Industries Ltd., Pfizer, Takeda, Johnson & Johnson, Alkem Laboratories Limited, GloxoSmithKline, Bayer, Cipla, Glenmark Pharmaceuticals Limited, and others.

Table Of Contents:

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Over-the-Counter (OTC) Drugs
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Over-the-Counter (OTC) Drugs Market By Product
1.2.2.1. Global Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Over-the-Counter (OTC) Drugs Market Revenue Share By Product in 2017
1.2.2.3. Analgesics
1.2.2.4. Cold
1.2.2.5. Cough & Flu Products
1.2.2.6. Weight Loss Products
1.2.2.7. Gastrointestinal Products
1.2.2.8. Skin Products
1.2.2.9. Mineral and Vitamin Supplements
1.2.2.10. Sleeping Aids
1.2.2.11. Ophthalmic Products
1.2.2.12. Others
1.2.3. Over-the-Counter (OTC) Drugs Market by Geography
1.2.3.1. Global Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017

CHAPTER 4. OVER-THE-COUNTER (OTC) DRUGS MARKET BY PRODUCT

4.1. Global Over-the-Counter (OTC) Drugs Revenue By Product
4.2. Analgesics
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Cold
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Cough & Flu Products
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Weight Loss Products
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Gastrointestinal Products
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Skin Products
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Mineral and Vitamin Supplements
4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.9. Sleeping Aids
4.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.10. Ophthalmic Products
4.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.11. Others
4.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

5.1. North America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Over-the-Counter (OTC) Drugs Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

6.1. Europe Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

7.1. Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

8.1. Latin America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

9.1. Middle East Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

10.1. Africa Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Johnson & Johnson
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Cipla
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Sun Pharmaceutical Industries Ltd.
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Dr. Reddy's Laboratories
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Merck KGaA
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Bayer
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Pfizer
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Alkem Laboratories Limited
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. GloxoSmithKline
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Sanofi
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Takeda
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. Glenmark Pharmaceuticals Limited
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies
11.13. Others
11.13.1. Company Snapshot
11.13.2. Overview
11.13.3. Financial Overview
11.13.4. Product Portfolio
11.13.5. Key Developments
11.13.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1171

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1171

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.